Análisis espacial e impacto ambiental en enfermedades transmisibles

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Monge S, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, et al. Influenza Other Respir Viruses. 2024 Apr;18(4):e13292.

PUBMED DOI

Development and Preliminary Validation of a Parkinsonism-Dystonia Scale for Infants and Young Children.

Pons R, Pearson TS, Perez-Dueñas B, Garcia-Cazorla A, Kurian MA, Dalivigka Z, Zouvelou V, Outsika C, Kokkinou E, Sigatullina-Bondarenko M, Darling A, O'Callaghan MDM, Spaull R, Steel DBD, Salamou E, Forjaz MJ, Rodriguez-Blazquez C. Development and Preliminary Validation of a Parkinsonism-Dystonia Scale for Infants and Young Children. Mov Disord. 2025 Aug;40(8):1669-1679.

PUBMED DOI

The future burden of type 2 diabetes in Belgium: a microsimulation model.

Mertens E, Ocira J, Sagastume D, Vasquez MS, Vandevijvere S, Peñalvo JL. The future burden of type 2 diabetes in Belgium: a microsimulation model. Popul Health Metr. 2024 Apr 23;22(1):8.

PUBMED DOI

Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega Study.

Sanchez-Rodriguez L, Galvez-Fernandez M, Rojas-Benedicto A, Domingo-Relloso A, Amigo N, Redon J, Monleon D, Saez G, Tellez-Plaza M, Martin-Escudero JC, Ramis R. Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega Study. Antioxidants (Basel). 2023 Dec 15;12(12):2122.

PUBMED DOI

Investigación